Results 71 to 80 of about 280,401 (218)

Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]

, 2019
Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B, Liccardi, A, Peschi, L, Pontieri, G, Ruggiero, A R, Urselli, F   +5 more
core   +2 more sources

Corneal Confocal Microscopy to Diagnose Peripheral Neuropathy: A Systematic Review and Meta‐Analysis

European Journal of Neurology, Volume 32, Issue 11, November 2025.
ABSTRACT Background and Objectives Peripheral neuropathy (PN) may be diagnosed late or may remain undiagnosed. Studies have shown that measurement of corneal nerve fiber length (CNFL) using corneal confocal microscopy (CCM) may have diagnostic utility in diabetic and other peripheral neuropathies. Methods The main databases [CENTRAL, Embase (Ovid), and
Ioannis N. Petropoulos, Omar A. Madani, Hoda Y. Gad, Ziyad R. Mahfoud, Georgios Ponirakis, Ross MacDonald, Rayaz A. Malik   +6 more
wiley   +1 more source

Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis

BioMed Research International, 2018
Background Graves' ophthalmopathy (GO) is a complicated autoimmune disease. Various therapies have been used to manage GO; however the optimum therapy is not clear. Glucocorticoids (GCs) therapy is the mainstay of treatment especially for active moderate
Xiaofang Tu, Yan Dong, Hongmei Zhang, Q. Su   +3 more
semanticscholar   +1 more source

Double Filtration Plasmapheresis for Thyroid Storm With Encephalopathy: A Case Report

Journal of Clinical Apheresis, Volume 40, Issue 5, October 2025.
ABSTRACT Thyroid storm is a life‐threatening endocrine emergency with a mortality rate of up to 17%. Standard treatment includes antithyroid drugs (ATD), β‐blockers, and glucocorticoids. However, some patients may require blood purification therapies, such as plasmapheresis, due to the ineffectiveness of standard treatments or contraindications like ...
Qisheng Lin, Haijiao Jin, Yao Xu, Yuanyuan Xie, Yijun Zhou, Renhua Lu   +5 more
wiley   +1 more source

Treatment of Graves' ophthalmopathy

Клиническая и экспериментальная тиреоидология, 2010
Graves' ophthalmopathy is one of most frequent extrathyroid manifestation of autoimmune thyroid diseases. In 3–5% cases it has severe progress and requires specific therapy.

doaj   +1 more source

The Increment of Choroidal Thickness in Euthyroid Graves' Ophthalmopathy: Is It an Early Sign of Venous Congestion?

Journal of Ophthalmology, 2018
Objective Clinical manifestations of Graves' ophthalmopathy (GO) are caused by the overcompression of orbital tissues within the restricted orbital bone cavity. Impaired ocular blood flow may disrupt the retinal microstructure and functions.
E. Çağıltay, F. Akay, O. Demir, E. Aydın, B. Akmaz, B. Pamuk   +5 more
semanticscholar   +1 more source

Development and psychometric properties of the Thai Graves’ ophthalmopathy quality of life (GO-QOL) questionnaire

Journal of Patient-Reported Outcomes, 2019
Purpose To develop and assess the psychometric properties of the Thai version of the Graves’ Ophthalmopathy Quality of Life (GO-QOL) questionnaire. Background Graves’ ophthalmopathy (GO) is a chronic condition that causes negative self-image and impaired
Mingkwan Lumyongsatien, Benjama Keeratidamkerngsakul, Kanokrat Pornpanich, Sumalee Vangveeravong, Preamjit Saonanon, Damrong Wiwatwongwana, Pornchai Mahaisavariya, Orapan Aryasit, Krit Pongpirul   +8 more
doaj   +1 more source

Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. [PDF]

, 2018
Thyroid-associated orbitopathy (TAO) is the most common autoimmune disease of the orbit. It occurs more often in patients presenting with hyperthyroidism, characteristic of Graves' disease, but may be associated with hypothyroidism or euthyroidism.
De Los Angeles Gracia, M., Eperon, S., Hamédani, M., Obéric, A., Turck, N.   +4 more
core   +3 more sources

Radiological Activity Score (RAS)—MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi‐Ethnic Thyroid Eye Disease Population

Clinical Endocrinology, Volume 103, Issue 3, Page 385-395, September 2025.
ABSTRACT Purpose Dysthyroid Optic Neuropathy (DON) is a sight threatening and diagnostically challenging complication of Thyroid Eye Disease (TED). We provide a comparative analysis of the MRI features associated between patietnts with and without DON. Methods Anonymised retrospective cohort study of patients with TED over eleven years.
Malik Moledina, Vickie Lee, Kunwar Bhatia, Gitta Madani, Claire Feeney, Nicole George, Nour Houbby, Daisy Metcalf, Natalie Man, Rajni Jain, Ahmad Aziz, Ravi Kumar Lingam   +11 more
wiley   +1 more source

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment [PDF]

Vojnosanitetski Pregled, 2012
Background/Aim. Graves’ ophthalmopthy is one of the most common causes of exophthalmos as well as the most common manifestation of Graves’ disease. The treatment of Graves’ ophthalmopathy includes ophthalmological and endocrinological therapy. The aim
Janićijević-Petrović Mirjana, Šarenac Tatjana, Srećković Sunčica, Petrović Marko, Vulović Dejan, Janićijević Katarina   +5 more
doaj   +1 more source